Fundus autofluorescence imaging of retinal dystrophies

Fundus autofluorescence (FAF) is a non-invasive imaging technique that enables the visualization of lipofuscin changes in the retinal pigment epithelium. This study aims to illustrate the spectrum of FAF changes in a variety of retinal dystrophies. For this purpose, we examined patients with retinal dystrophies such as Stargardt disease, Best vitelliform macular dystrophy, and retinal dystrophies associated with mutations in the peripherin/RDS gene. All retinal dystrophies were confirmed by molecular genetic analysis. A broad range of characteristic FAF patterns was observed. Our results indicate that FAF imaging constitutes a useful additive tool in the diagnosis and follow-up of various retinal dystrophies.

[1]  J. Kobrin,et al.  Histopathology of Best's macular dystrophy. , 1982, Archives of ophthalmology.

[2]  B. Wissinger,et al.  MORPHOLOGY AND FUNCTIONAL CHARACTERISTICS IN ADULT VITELLIFORM MACULAR DYSTROPHY , 2004, Retina.

[3]  H. Gin,et al.  Prevalence of macular pattern dystrophy in maternally inherited diabetes and deafness. GEDIAM Group. , 1999, Ophthalmology.

[4]  A. Bird,et al.  Fundus autofluorescence in Stargardt macular dystrophy-fundus flavimaculatus. , 2004, American journal of ophthalmology.

[5]  M. Kiyosawa,et al.  Ciliary and retinal changes in myotonic dystrophy. , 1984, Archives of ophthalmology.

[6]  B. Lorenz,et al.  Phenotypes of 16 Stargardt macular dystrophy/fundus flavimaculatus patients with known ABCA4 mutations and evaluation of genotype–phenotype correlation , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[7]  Jean Bennett,et al.  Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. , 2004, Human molecular genetics.

[8]  C K Dorey,et al.  In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. , 1995, Investigative ophthalmology & visual science.

[9]  F W Fitzke,et al.  In vivo fundus autofluorescence in macular dystrophies. , 1997, Archives of ophthalmology.

[10]  Club Jules Gonin,et al.  Graefe's archive for clinical and experimental ophthalmology , 1982 .

[11]  T. Meigen,et al.  Clinical findings in a multigeneration family with autosomal dominant central areolar choroidal dystrophy associated with an Arg195Leu mutation in the peripherin/RDS gene. , 2006, Archives of ophthalmology.

[12]  M. Lavail,et al.  Light and inherited retinal degeneration , 2006, British Journal of Ophthalmology.

[13]  C. Wadelius,et al.  Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2). , 2007, Experimental eye research.

[14]  E. R. Büchi,et al.  Genetic heterogeneity in autosomal dominant pattern dystrophy of the retina. , 1996, Molecular vision.

[15]  M. Boulton,et al.  RPE lipofuscin and its role in retinal pathobiology. , 2005, Experimental eye research.

[16]  A. Deutman,et al.  The development of central areolar choroidal dystrophy , 1996, Graefe's Archive for Clinical and Experimental Ophthalmology.

[17]  M. Małecki.  Genetics of type 2 diabetes mellitus. , 2005, Diabetes research and clinical practice.

[18]  B. J. Klevering,et al.  Clinical and genetic heterogeneity in multifocal vitelliform dystrophy. , 2007, Archives of ophthalmology.

[19]  A. Deutman,et al.  Butterfly-shaped pigment dystrophy of the fovea. , 1970, Archives of ophthalmology.

[20]  E. Rodriguez-Boulan,et al.  The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells , 2007, Proceedings of the National Academy of Sciences.

[21]  K. Nakanishi,et al.  A2E, a fluorophore of RPE lipofuscin, can destabilize membrane. , 2006, Advances in experimental medicine and biology.

[22]  J. Sparrow,et al.  Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. , 2001, Investigative ophthalmology & visual science.

[23]  M. Metzker,et al.  Identification of the gene responsible for Best macular dystrophy , 1998, Nature Genetics.

[24]  G. Silvestri,et al.  Fine localisation of the gene for central areolar choroidal dystrophy on chromosome 17p. , 1998, Journal of medical genetics.

[25]  Sander R. Dubovy,et al.  ADULT‐ONSET FOVEOMACULAR PIGMENT EPITHELIAL DYSTROPHY: Clinicopathologic Correlation of Three Cases , 2000, Retina.

[26]  K. Nakanishi,et al.  The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. , 2000, Investigative ophthalmology & visual science.

[27]  J. Lupski,et al.  A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophy , 1997, Nature Genetics.

[28]  B. Lorenz,et al.  Fundus autofluorescence in children and teenagers with hereditary retinal diseases , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[29]  J. Weiter,et al.  Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. , 1986, Investigative ophthalmology & visual science.

[30]  M. Nakagawa,et al.  Retinal manifestations in mitochondrial diseases associated with mitochondrial DNA mutation. , 1998, Acta ophthalmologica Scandinavica.

[31]  K. Freund,et al.  Vitelliform macular dystrophy. , 2014, JAMA ophthalmology.

[32]  D. Zack,et al.  Butterfly-shaped pattern dystrophy: a genetic, clinical, and histopathological report. , 2002, Archives of ophthalmology.

[33]  A. Bird,et al.  Clinical features of codon 172 RDS macular dystrophy: similar phenotype in 12 families. , 1999, Archives of ophthalmology.

[34]  A. Deutman,et al.  Autosomal dominant central areolar choroidal dystrophy caused by a mutation in codon 142 in the peripherin/RDS gene. , 1996, American journal of ophthalmology.

[35]  S. Jockusch,et al.  A2E-epoxides Damage DNA in Retinal Pigment Epithelial Cells , 2003, The Journal of Biological Chemistry.

[36]  G. Travis,et al.  Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  E. Stone,et al.  Differential macular and peripheral expression of bestrophin in human eyes and its implication for best disease. , 2007, Investigative ophthalmology & visual science.

[38]  Alexander Sumaroka,et al.  In vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosa. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  K. Nakanishi,et al.  A2E, a byproduct of the visual cycle , 2003, Vision Research.

[40]  A. Bird,et al.  Pattern ERG correlates of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. , 2003, Investigative ophthalmology & visual science.

[41]  B. S. Fine,et al.  Patterned dystrophies of the retinal pigment epithelium. , 1977, Archives of ophthalmology.

[42]  Hendrik P N Scholl,et al.  Localized retinal electrophysiological and fundus autofluorescence imaging abnormalities in maternal inherited diabetes and deafness. , 2004, Investigative ophthalmology & visual science.

[43]  U. Kellner,et al.  Late onset is common in best macular dystrophy associated with VMD2 gene mutations. , 2005, Ophthalmology.

[44]  Y. Jang,et al.  Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium , 2006, Proceedings of the National Academy of Sciences.

[45]  H. Burian,et al.  Ocular changes in myotonic dystrophy. , 1967, American journal of ophthalmology.

[46]  Vision Research , 1961, Nature.

[47]  A. Bird,et al.  Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity , 2006, British Journal of Ophthalmology.

[48]  A. Deutman,et al.  Pigment dispersion syndrome and pigmented pattern dystrophy of retinal pigment epithelium. , 1983, The British journal of ophthalmology.

[49]  J. Weiter,et al.  In vivo measurement of lipofuscin in Stargardt's disease--Fundus flavimaculatus. , 1995, Investigative ophthalmology & visual science.

[50]  R. Radu,et al.  Characterization of Native Retinal Fluorophores Involved in Biosynthesis of A2E and Lipofuscin-associated Retinopathies* , 2006, Journal of Biological Chemistry.

[51]  M. Hawlina,et al.  Fundus Autofluorescence Imaging in Best's Vitelliform Dystrophy , 2003, Klinische Monatsblatter fur Augenheilkunde.

[52]  A. Pinckers.  Patterned dystrophies of the retinal pigment epithelium. A review. , 1988, Ophthalmic paediatrics and genetics.

[53]  J. Ott,et al.  Genetic and phenotypic heterogeneity in pattern dystrophy , 2005, British Journal of Ophthalmology.

[54]  S. Fine,et al.  A histopathologic study of Best's macular dystrophy. , 1982, Archives of ophthalmology.

[55]  A. Deutman,et al.  Genetic heterogeneity of butterfly-shaped pigment dystrophy of the fovea. , 2003, Molecular vision.

[56]  R. Fagan,et al.  PATTERN DYSTROPHY OF THE PIGMENT EPITHELIUM , 1981, Retina.

[57]  K. Nakanishi,et al.  A2E, a fluorophore of RPE lipofuscin: can it cause RPE degeneration? , 2003, Advances in experimental medicine and biology.

[58]  B. J. Klevering,et al.  Mutations in the peripherin/RDS gene are an important cause of multifocal pattern dystrophy simulating STGD1/fundus flavimaculatus , 2007, British Journal of Ophthalmology.

[59]  R. L. Font,et al.  Foveomacular vitelliform dystrophy, adult type. A clinicopathologic study including electron microscopic observations. , 1985, Ophthalmology.

[60]  M. Katz,et al.  Fluorophores of the human retinal pigment epithelium: separation and spectral characterization. , 1988, Experimental eye research.

[61]  B. Lorenz,et al.  Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[62]  D. Birch,et al.  Insights into the Function of Rim Protein in Photoreceptors and Etiology of Stargardt's Disease from the Phenotype in abcr Knockout Mice , 1999, Cell.

[63]  E. Stone,et al.  Late development of vitelliform lesions and flecks in a patient with best disease: clinicopathologic correlation. , 2005, Archives of ophthalmology.

[64]  T. Aleman,et al.  ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina. , 2005, Investigative ophthalmology & visual science.

[65]  G. Fishman,et al.  Histopathologic findings in Best's vitelliform macular dystrophy. , 1988, Archives of ophthalmology.

[66]  A. Bird,et al.  Distribution of pigment epithelium autofluorescence in retinal disease state recorded in vivo and its change over time , 1999, Graefe's Archive for Clinical and Experimental Ophthalmology.

[67]  A. Edwards,et al.  Peripherin/RDS and VMD2 mutations in macular dystrophies with adult-onset vitelliform lesion. , 2006, Molecular vision.

[68]  P. Liao,et al.  Stereoscopic Atlas of Macular Diseases. Diagnosis and Treatment , 1987, The Yale Journal of Biology and Medicine.

[69]  T. Aleman,et al.  Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations. , 2007, Journal of the Optical Society of America. A, Optics, image science, and vision.

[70]  C K Dorey,et al.  Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. , 2001, Investigative ophthalmology & visual science.